Pharma in brief image

Current directions in regulatory and intellectual property law in Canadian pharmaceutical cases

Publication |  April 2016

Pharma in Brief 2015 year in review pdf

Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.

Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)



Contact

Jordana Sanft
Jordana Sanft

Recent publications

greenhouse gas

Canada: Focus on climate change disclosure continues with LEEFF

Companies that receive LEEFF funding will be required to complete annual climate change reporting and should consider utilizing the TCFD standards to inform reporting strategies.

Publication | June 3 2020 - 2 PM ET

Climate change and sustainability

Energy renewables solar panels windfarm

L’hydrogène en France : état des lieux et perspectives

En France, plus de 900 000 tonnes d’hydrogène sont produites chaque année pour couvrir les besoins de l’industrie française.

Publication | June 03, 2020

Energy

US: New DOJ guidance on corporate compliance programs emphasizes dynamic program design and implementation

The DOJ announces the latest set of updates to its “Evaluation of Corporate Compliance Programs” policy.

Publication | June 3, 2020

Regulation and investigations

site search

Subscribe and stay up to date with the latest legal news, information and events...

Register now